CoChat
Sign Up
Cited by 182Gestational Diabetes Research and ManagementPregnancy and preeclampsia studiesDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.

Metabolic syndrome in pregnancy and risk for adverse pregnancy outcomes: A prospective cohort of nulliparous women

Open access
Grieger, Jessica A., Bianco-Miotto, Tina, Grzeskowiak, Luke E., Leemaqz, Shalem Y., Poston, Lucilla, McCowan, Lesley M., Kenny, Louise C., Myers, Jenny E., Walker, James J., Dekker, Gus A., Roberts, Claire T.·2018·PLOS Medicine
DOI 10.1371/journal.pmed.1002710PMC PMC6279018
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: Obesity increases the risk for developing gestational diabetes mellitus (GDM) and preeclampsia (PE), which both associate with increased risk for type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) in women in later life. In the general population, metabolic syndrome (MetS) associates with T2DM and CVD. The impact of maternal MetS on pregnancy outcomes, in nulliparous pregnant women, has not been investigated. METHODS AND FINDINGS: Low-risk, nulliparous women were recruited to the multi-centre, international prospective Screening for Pregnancy Endpoints (SCOPE) cohort between 11 November 2004 and 28 February 2011. Women were assessed for a range of demographic, lifestyle, and metabolic health variables at 15 ± 1 weeks' gestation. MetS was defined according to International Diabetes Federation (IDF) criteria for adults: waist circumference ≥80 cm, along with any 2 of the following: raised trigycerides (≥1.70 mmol/l [≥150 mg/dl]), reduced high-density lipoprotein cholesterol (<1.29 mmol/l [<50 mg/dl]), raised blood pressure (BP) (i.e., systolic BP ≥130 mm Hg or diastolic BP ≥85 mm Hg), or raised plasma glucose (≥5.6 mmol/l). Log-binomial regression analyses were used to examine the risk for each pregnancy outcome (GDM, PE, large for gestational age [LGA], small for gestational age [SGA], and spontaneous preterm birth [sPTB]) with each of the 5 individual components for MetS and as a composite measure (i.e., MetS, as defined by the IDF). The relative risks, adjusted for maternal BMI, age, study centre, ethnicity, socioeconomic index, physical activity, smoking status, depression status, and fetal sex, are reported. A total of 5,530 women were included, and 12.3% (n = 684) had MetS. Women with MetS were at an increased risk for PE by a factor of 1.63 (95% CI 1.23 to 2.15) and for GDM by 3.71 (95% CI 2.42 to 5.67). In absolute terms, for PE, women with MetS had an adjusted excess risk of 2.52% (95% CI 1.51% to 4.11%) and, for GDM, had an adjusted excess risk of 8.66% (95% CI 5.38% to 13.94%). Diagnosis of MetS was not associated with increased risk for LGA, SGA, or sPTB. Increasing BMI in combination with MetS increased the estimated probability for GDM and decreased the probability of an uncomplicated pregnancy. Limitations of this study are that there are several different definitions for MetS in the adult population, and as there are none for pregnancy, we cannot be sure that the IDF criteria are the most appropriate definition for pregnancy. Furthermore, MetS was assessed in the first trimester and may not reflect pre-pregnancy metabolic health status. CONCLUSIONS: We did not compare the impact of individual metabolic components with that of MetS as a composite, and therefore cannot conclude that MetS is better at identifying women at risk. However, more than half of the women who had MetS in early pregnancy developed a pregnancy complication compared with just over a third of women who did not have MetS. Furthermore, while increasing BMI increases the probability of GDM, the addition of MetS exacerbates this probability. Further studies are required to determine if individual MetS components act synergistically or independently.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1002710

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 61 references

1 of the 61 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Items 101–182 of 182

Related

See all

Metadata

Authors
Grieger, J. A., Bianco-Miotto, T., Grzeskowiak, L. E., Leemaqz, S. Y., Poston, L., McCowan, L. M., Kenny, L. C., Myers, J. E., Walker, J. J., Dekker, G. A., & Roberts, C. T.
Affiliations
  • The University of Adelaide (AU)
  • St Thomas' Hospital (GB)
  • University of Auckland (NZ)
  • University of Liverpool (GB)
  • University of Manchester (GB)
  • University of Leeds (GB)
Corresponding author
  • Grieger, Jessica A.
  • Grzeskowiak, Luke E.
  • Leemaqz, Shalem Y.
  • Poston, Lucilla
  • McCowan, Lesley M.
  • Kenny, Louise C.
  • Myers, Jenny E.
  • Walker, James J.
  • Roberts, Claire T.
ORCID
Venue
PLOS Medicine
Publisher
Public Library of Science (PLoS)
Published
2018-12-04
Volume
15
Issue
12
Pages
e1002710
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
DOI
10.1371/journal.pmed.1002710
PMC
PMC6279018
OpenAlex
W2902051656
Cited by
182
References
61
Citations by year
2026: 18 · 2025: 18 · 2024: 25 · 2023: 39 · 2022: 30 · 2021: 22 · 2020: 21 · 2019: 9
FWCI
14.60
Type
journal article
Language
en
Open access
Licence
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion, cc-by)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Research Portal (King's College London) (submittedVersion, other-oa)
Funders
  • Health Research Board (12/RC/2272, CSA/2007/2)
  • Government of South Australia
  • Auckland District Health Board
  • Australian Government
  • National Institute for Health and Care Research (NIHR-CS-011-020)
  • King's College London
  • University of Leeds
  • Science Foundation Ireland (12/RC/2272, 12/RC/)
  • Cerebra
  • Tommy's
  • Directorate for Biological Sciences
  • Medical Research Council
  • National Health and Medical Research Council (1099422, 1020749, 1070421)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
metabolic syndrome, pregnancy, nulliparous women, gestational diabetes mellitus, preeclampsia, adverse pregnancy outcomes, large for gestational age, small for gestational age, preterm birth, type 2 diabetes risk, cardiovascular risk, maternal obesity, waist circumference, hypertriglyceridemia, low HDL cholesterol, hypertension in pregnancy
MeSH terms
Adult, Australia, Female, United Kingdom, Humans, Ireland, New Zealand, Parity, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Prospective Studies, Risk Factors, Cohort Studies, Metabolic Syndrome, Internationality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review